-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only
Scientific response to the "world's first pain"!
Trigeminal neuralgia is a clinically common cranial nerve disease, with an age of onset of 28~89 years old
.
The latest WHO survey data shows that trigeminal neuralgia is tending to be younger, and the prevalence of the population is increasing
.
Paroxysmal recurrent episodes, facial numbness, hypoesthesia, corneal dysreflexia, masticatory muscle weakness, and atrophy cause great distress
.
Although they are all trigeminal neuralgia, the classification is very different! Let's take a look!
One
Classification based on etiology
▍Primary trigeminal neuralgia (most common, also known as idiopathic trigeminal neuralgia)
- Location of pain: within the distribution of
the trigeminal nerve.
- Nature of pain: transient severe pain, severe pain like electric shock, knife cut, and tear.
- Attack time: recurrent, sudden stop, each lasting a few seconds to tens of seconds, the interval period is completely normal
.
- Precipitating factors: Random facial movements such as speaking, chewing, brushing, and washing the face or touching an area of the face (such as the upper lip, nose, supraorbital foramen, infraorbital foramen, and oral gums).
- Accompanying symptoms: dare not eat, wash face, haggard face, depressed; Severe with painful tics (ipsilateral muscle twitches, facial flushing, lacrimation, and salivation).
▍Secondary trigeminal neuralgia (also known as symptomatic trigeminal neuralgia)
- Age of onset: under 40 years of age
.
- Duration of seizures: longer, or persistent, episodic worsening
.
- Predisposing factors: There are no "trigger points"
.
- Signs: hypoesthesia, absence, or hypersensitivity in the innervated trigeminal nerve, with corneal dysreflexia, masticatory muscle weakness, and atrophy
in some cases.
- Ancillary examinations: CT and MRI can confirm the diagnosis
.
Two
Classification is based on the characteristics of pain symptoms
▍Typical trigeminal neuralgia
- The pain is paroxysmal and recurrent
.
- There are definite intervals and they are completely normal
.
- There are "trigger points" and clear inducing actions
.
- The trigeminal nerve is functioning normally
.
▍Atypical trigeminal neuralgia
- Pain practice is prolonged or even persistent, but may be paroxysmal and exacerbated
.
- No "trigger point" phenomenon
.
- Manifestations of trigeminal hypofunction (facial numbness, hypoesthesia, corneal dysreflexia, masticatory muscle weakness, and atrophy)
are present.
What are the treatments for trigeminal neuralgia? How is it managed after surgery?
For more diagnosis and treatment guides, open [Decision Assistant App] a query, and talk to major guides! 👇
1.
Scan the QR code
below 2.
Download the Clinical Decision Assistant App 3.
Open the Decision Assistant App
, Click the icon
4.
Search for the guide you want to see
Download the app and learn a new guide every day!
Download the Decision Assistant App, the guide is free at any time~References:
[1] Chinese expert consensus on the diagnosis and treatment of trigeminal neuralgia
▼▼▼Click to read the original article to download the App